PROCEPT BioRobotics (PRCT) Change in Accured Expenses (2020 - 2026)
PROCEPT BioRobotics (PRCT) posted quarterly Change in Accured Expenses of -$4.7 million for Q1 2026, up 28.55% year-over-year from -$3.6 million in Q1 2025, and down 7112.31% quarter-over-quarter from -$65000.0 in Q4 2025.
PROCEPT BioRobotics (PRCT) Change in Accured Expenses (2020 - 2026) Analysis & Trends
PROCEPT BioRobotics (PRCT) has reported Change in Accured Expenses for 7 consecutive years, with -$4.7 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Change in Accured Expenses rose 28.55% year-over-year to -$4.7 million; the TTM figure through Mar 2026 stood at $2.0 million (up 131.2% YoY), while the FY2025 annual figure was $142000.0, up 5.97% from the prior year.
- Change in Accured Expenses eased to -$4.7 million in Q1 2026 per PRCT's latest filing, from -$65000.0 in the prior quarter.
- Across five years, Change in Accured Expenses topped out at $8.1 million in Q2 2025 and bottomed at -$6.6 million in Q1 2025.
- Historically, Change in Accured Expenses has averaged $352823.5 across 5 years, with a median of $346000.0 in 2023.
- On a YoY basis, Change in Accured Expenses climbed as much as 480.56% in 2025 and fell as far as 20603.12% in 2025.
- PROCEPT BioRobotics' Change in Accured Expenses stood at $5.7 million in 2022, then plunged by 44.81% to $3.1 million in 2023, then plunged by 158.19% to -$1.8 million in 2024, then soared by 96.42% to -$65000.0 in 2025, then sank by 7112.31% to -$4.7 million in 2026.
- Business Quant data shows PRCT's Change in Accured Expenses at -$4.7 million in Q1 2026, -$65000.0 in Q4 2025, and -$1.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.95 Bn | 193.35 Bn | 7.27 Bn | - |
| 2 | Stryker | 128.10 Bn | 124.63 Bn | 4.50 Bn | 298.00 Mn |
| 3 | Medtronic | 118.91 Bn | 109.69 Bn | 6.41 Bn | 123.00 Mn |
| 4 | Boston Scientific | 73.43 Bn | 72.89 Bn | 3.85 Bn | 234.00 Mn |
| 5 | Edwards Lifesciences | 51.91 Bn | 47.66 Bn | 1.35 Bn | 123.70 Mn |
| 6 | Dexcom | 34.52 Bn | 32.58 Bn | 830.00 Mn | 112.90 Mn |
| 7 | GE HealthCare Technologies | 33.94 Bn | 31.83 Bn | 2.18 Bn | 19.00 Mn |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn | 43.01 Mn |
| 9 | Steris | 23.14 Bn | 22.66 Bn | 684.20 Mn | 4.80 Mn |
| 10 | PROCEPT BioRobotics | 1.22 Bn | 940.44 Mn | 62.38 Mn | 1.96 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.96 Mn |
| Jun 30, 2026 | 1.96 Mn |
| Mar 31, 2026 | -4.69 Mn |
| Mar 31, 2026 | -4.69 Mn |
| Dec 31, 2025 | -65,000.00 |
| Dec 31, 2025 | -65,000.00 |
| Sep 30, 2025 | -1.35 Mn |
| Sep 30, 2025 | -1.35 Mn |
| Jun 30, 2025 | 8.12 Mn |
| Jun 30, 2025 | 8.12 Mn |
| Mar 31, 2025 | -6.56 Mn |
| Mar 31, 2025 | -6.56 Mn |
| Dec 31, 2024 | -1.82 Mn |
| Dec 31, 2024 | -1.82 Mn |
| Sep 30, 2024 | 518,000.00 |
| Sep 30, 2024 | 518,000.00 |
| Jun 30, 2024 | 1.40 Mn |
| Jun 30, 2024 | 1.40 Mn |
| Mar 31, 2024 | 32,000.00 |
| Mar 31, 2024 | 32,000.00 |